Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

37.36
Delayed Data
As of 4:02pm ET
 +0.28 / +0.76%
Today’s Change
30.89
Today|||52-Week Range
57.44
+4.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
AssetsCash736.9M2.0B2.2B2.7B
 
 
 
 
 
Short Term Investment Cash-1.7B1.2B196.7M652.0M
 
 
 
 
 
Cash & Short Term Investments1.6B2.4B2.6B3.0B
 
 
 
 
 
 
ReceivablesReceivables3.1B3.1B2.6B3.4B
 
 
 
 
 
 
InventoriesInventories2.0B2.0B2.2B2.0B
 
 
 
 
 
 
Current AssetsOther Current Assets401.8M409.2M412.6M0.00
 
 
 
 
Current Assets7.1B7.9B7.8B8.5B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------8.2B
 
 
Depreciation-------3.9B
 
 
Intangible Assets329.9M314.9M430.0M385.0M
 
 
 
 
 
Other Assets329.9M314.9M430.0M385.0M
 
 
 
 
 
Total Assets12.6B13.2B13.2B13.8B
 
 
 
 
 
 
LiabilitiesAccounts Payable572.0M796.4M673.4M852.7M
 
 
 
 
 
Short Term Debt62.1M60.6M68.8M32.5M
 
 
 
 
 
Accrued Expenses------986.3M
 
 
Other Current Liabilities4.9B4.7B4.7B4.6B
 
 
 
 
 
Other Liabilities6.3B6.2B6.3B6.7B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-917.1M-664.4M-404.6M-378.7M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
 
Total Liabilities6.9B6.8B6.9B7.4B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity5.7B6.4B6.2B6.4B
 
 
 
 
 
Total Shareholder Equity5.7B6.4B6.2B6.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.0B2.0B2.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.